dc.contributor.author | Manchanda, R | en_US |
dc.contributor.author | Menon, U | en_US |
dc.date.accessioned | 2016-02-19T11:38:53Z | |
dc.date.available | 2016-01-01 | en_US |
dc.date.issued | 2016-02 | en_US |
dc.date.submitted | 2016-02-02T09:47:59.189Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/11153 | |
dc.format.extent | 463 - ? | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | BJOG | en_US |
dc.rights | This is the peer reviewed version of the following article: Manchanda, R. and Menon, U. (2016), Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial. BJOG: An International Journal of Obstetrics & Gynaecology, 123: 463. doi: 10.1111/1471-0528.13741, which has been published in final form at http://dx.doi.org/10.1111/1471-0528.13741. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. | |
dc.subject | Clinical Trials as Topic | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Ovarian Neoplasms | en_US |
dc.subject | Prophylactic Surgical Procedures | en_US |
dc.subject | Salpingectomy | en_US |
dc.title | Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: There is lack of clarity on a number of key issues. | en_US |
dc.type | Article | |
dc.rights.holder | © 2016 Royal College of Obstetricians and Gynaecologists. | |
dc.identifier.doi | 10.1111/1471-0528.13741 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/26810679 | en_US |
pubs.issue | 3 | en_US |
pubs.notes | 12 months | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 123 | en_US |